Breaking News, Financial News

Financial Report: Allergan

Specialty pharma sales up 12% in the quarter

Allergan

4Q Revenues: $1.9 billion (+14%)

4Q Earnings: $539.1 million (+73%)

FY Revenues: $7.2 billion (+15%)

FY Earnings: $1.5 billion (+55%)

Comments: Specialty pharmaceutical sales increased 12% in the quarter to $1.6 billion. Medical devices sales increased 21% to $282.3 million. In the quarter, Actavis and Allergan entered an agreement under which Actavis will acquire Allergan in transaction valued at approximately $66 billion.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters